MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/md.0000000000033948

Медицинская библиотека · Medicine · 2023

Development of giant cell arteritis after vaccination against SARS-CoV2: A case report and literature review.

Wakabayashi Hiroki, Iwayanagi Misa, Sakai Daiki, Sugiura Yoshiya, Hiruta Nobuyuki, Matsuzawa Yasuo, Kaneko Kaichi

ОбзорКлинический случайСтатьяПеревод в очереди

Аннотация

RATIONALE: Giant cell arteritis (GCA) is an autoimmune vasculitis that affects large and medium-sized blood vessels. The mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has been associated with the development of immune-mediated diseases. In this article, we present a case of GCA that developed after vaccination against SARS-CoV2.

PATIENT CONCERNS: A 77-year-old man developed fever, general fatigue, and headache 1 day after the third dose of vaccination against SARS-CoV2. Nodular swelling and tenderness of the bilateral temporal arteries were observed.

DIAGNOSES: Although right temporal artery biopsies were negative, the patient was diagnosed with GCA based on criteria established by the American College of Rheumatology for the classification of GCA.

INTERVENTIONS: The patient received methylprednisolone 1000 mg for 3 days. This was followed by prednisolone 1 mg/kg/d, which was decreased by 10 mg every week to 30 mg. From day 16 of hospitalization, the patient received tocilizumab 162 mg/wk every other week.

OUTCOMES: There was no occurrence of acute side effects. After 38 days of treatment, the condition improved and the patient was discharged from the hospital; as stated above, the dose of prednisolone was tapered to 30 mg/d.

LESSONS: We experienced a case of GCA that occurred immediately after vaccination against SARS-CoV2 with an mRNA vaccine. Early signs of GCA include fever, fatigue, and headache, and often resemble those noted after vaccination against SARS-CoV2. The potential presence of GCA should be determined in individuals with persistent fever and headache after vaccination against SARS-CoV2.

Для цитирования: Wakabayashi Hiroki, Iwayanagi Misa, Sakai Daiki, Sugiura Yoshiya, Hiruta Nobuyuki, Matsuzawa Yasuo, Kaneko Kaichi. Development of giant cell arteritis after vaccination against SARS-CoV2: A case report and literature review.. Medicine. 2023. DOI: 10.1097/md.0000000000033948.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.